Log in to save to my catalogue

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin v...

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin v...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6d2e3327f8224302849b5a783edc099f

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial

About this item

Full title

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial

Publisher

England: BioMed Central Ltd

Journal title

Respiratory research, 2019-10, Vol.20 (1), p.237-12, Article 237

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

In the BACE trial, a 3-month (3 m) intervention with azithromycin, initiated at the onset of an infectious COPD exacerbation requiring hospitalization, decreased the rate of a first treatment failure (TF); the composite of treatment intensification (TI), step-up in hospital care (SH) and mortality.
(1) To investigate the intervention's effect on...

Alternative Titles

Full title

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6d2e3327f8224302849b5a783edc099f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6d2e3327f8224302849b5a783edc099f

Other Identifiers

ISSN

1465-993X,1465-9921

E-ISSN

1465-993X

DOI

10.1186/s12931-019-1208-6

How to access this item